- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
<b>Summary Report of Questionnaire Survey on Current Situation and Issues of Human Mass Balance Study Using Radioisotopes in Japan</b>
-
- HASEGAWA Hiroshi
- Non-Clinical Evaluation Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
-
- FURUTA Shigeru
- Non-Clinical Evaluation Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
-
- KURIBAYASHI Shunji
- Non-Clinical Evaluation Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
-
- TSUDA Minoru
- Non-Clinical Evaluation Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
-
- SATSUKAWA Masahiro
- Non-Clinical Evaluation Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
-
- SUZUKI Motohiro
- Non-Clinical Evaluation Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
-
- ISHII Satoru
- Non-Clinical Evaluation Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
-
- KONDO Hiroshi
- Non-Clinical Evaluation Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
-
- MINATO Kouichi
- Non-Clinical Evaluation Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
-
- SATO Takashi
- Non-Clinical Evaluation Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
-
- TSUTSUI Masaru
- Non-Clinical Evaluation Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
-
- KURAHASHI Yoshikazu
- Non-Clinical Evaluation Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
-
- MIURA Shin-ichi
- Non-Clinical Evaluation Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
-
- NAKAMURA Kazuichi
- Non-Clinical Evaluation Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA)
Bibliographic Information
- Other Title
-
- <b>本邦における放射性同位元素を使用したヒトマスバランス試験の現状と課題点に関するアンケート調査結果報告</b>
Search this article
Description
A questionnaire on conventional “human mass balance (MB) study” was sent to 61 pharmaceutical companies affiliated with the Japan Pharmaceutical Manufacturers Association in 2013, and 48 companies responded. The strategy and design of MB study were also investigated with respect to the approved new molecular entities in Japan and the US from 2002 to 2013. Most companies conduct MB study during proof-of-concept clinical trials or before phase III studies. Additionally, FDA and ICH guidance have encouraged the companies to perform MB studies routinely and/or in an earlier phase. The present survey suggests that MB study has occupied an important position in new drug development, and that implementation of the study appears to be judged carefully taking the necessity into consideration.
Journal
-
- Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
-
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 46 (6), 265-272, 2015
The Japanese Society of Clinical Pharmacology and Therapeutics
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390282680344351360
-
- NII Article ID
- 130005113526
-
- ISSN
- 18828272
- 03881601
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed